Mark Cuban Cost Plus Drug Co., a mail-order pharmacy with thousands of generics and a handful of brand-name drugs, has partnered with two mail-order pharmacies. 

AstraZeneca's approved lung cancer drug Tagrisso (osimertinib) reduced the risk of death by 51 percent in a phase 3 study that involved 682 patients with non-small cell lung cancer. 

As local pharmacies and hospitals struggle to staff teams with enough pharmacy technicians, Kavish Choudhary, PharmD, chief pharmacy officer of University of Utah Health, told Becker's five pieces of advice.

As drugmakers continue to delay resupply dates for cisplatin, a cancer drug in a monthslong shortage, the FDA allowed a China-based pharmaceutical company to temporarily import some solutions. 

Mark Cuban Cost Plus Drug Co. will raise its pharmacy labor fee from $3 to $5, effective Sept. 1.

A phase 3 trial of pharmaceutical giant Pfizer's newly developed antibiotic combination revealed positive results, revealing a promising treatment for superbug infections, according to a June 1 press release.

The National Institutes of Health's cancer unit is launching the largest study to test combinations of cancer drugs in comparison to the drugs on their own, the organization said June 1. 

After CMS announced plans to preserve availability of Alzheimer's drugs, the Alzheimer's Association has issued a statement in opposition of it.

University of Florida Health's specialty pharmacy recently expanded its list of medications and accepted insurance plans. 

As the U.S. experiences the highest number of drug shortages in 10 years, the FDA and the American Society of Health-System Pharmacists reported 17 new shortages in May.